February 26, 2008
Court Considers Protecting Drug Makers From Lawsuits
WASHINGTON — Less than a week after issuing a sweeping ruling that bars most lawsuits against medical device makers, the Supreme Court heard arguments Monday in the first of two cases that could determine whether drug makers receive similar protection.
Read article in the New York Times (USA)
Comment: Needless to say, the ruling that is being sought here is a last desperate attempt to avert the imminent collapse of the pharmaceutical investment business with patented drugs. Whatever the Supreme Court eventually rules in these cases, the truth about the pharmaceutical industry – including its toxic chemotherapy and antiretroviral drugs - will remain unchanged: While pretending to deliver health to the world, its entire existence is based on promoting diseases as multi-billion dollar markets for patented drugs.
February 25, 2008
Wyeth, Pfizer Ordered to Pay $2.75 Million Over Drugs
Hormone-replacement drugs made by Wyeth and a Pfizer Inc. unit caused an Arkansas woman's breast cancer and she deserves at least $2.75 million in damages, jurors ruled in the companies' first loss in federal court. Jurors in Little Rock, Arkansas, deliberated 12 hours over two days before finding the combination of Wyeth's Premarin and Pharmacia & Upjohn's Provera menopause drugs helped cause Donna Scroggin's cancer. The former factory worker had a double mastectomy after taking hormone-replacement drugs for about 10 years.
Read article at bloomberg.com